Bintrafusp alfa (BA) is a first-in-class bifunctional anti-PD-L1/TGF-β receptor II fusion protein designed to inhibit PD-L1-mediated immunosuppression as well as TGF-β levels in the tumor microenvironment. This evidence concerns the gene TGFB1 and neoplasm.